Health Catalyst Overview
Health Catalyst Target Price
Analysts' 12-month price predictions for HCAT.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.72
Average Target Price
$2.25
30.8% upside
30.8% upside3 analysts in the last 4 months
High: $3 | Low: $1.75
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Stephens | $1.75 | 1.7% upside |  |
| 2026-03-13 | Raymond JamesSarah James | $3 | 74.4% upside | |
| 2026-03-13 | Canaccord GenuityRichard Close | $2 | 16.3% upside | |
| 2025-10-08 | Evercore ISI | $3 | 74.4% upside | |
| 2025-10-08 | KeyBanc | $4 | 132.6% upside | |
| 2025-08-29 | Summit Redstone Partners | $5 | 190.7% upside | |
| 2025-08-29 | Canaccord GenuityRichard Close | $5 | 190.7% upside | |
| 2025-04-16 | KeyBancScott Schoenhaus | $5 | 190.7% upside | |
| 2025-03-06 | Stephens | $5 | 190.7% upside | |
| 2025-01-14 | RBC CapitalSean Dodge | $7 | 307% upside | |
| 2024-09-03 | Canaccord GenuityRichard Close | $11 | 539.5% upside | |
| 2024-08-26 | Piper SandlerJessica Tassan | $11 | 539.5% upside | |
| 2024-08-08 | StephensJeff Garro | $7 | 307% upside | |
| 2024-06-06 | Piper SandlerJessica Tassan | $14 | 714% upside | |
| 2024-01-26 | GuggenheimJack Wallace | $14 | 714% upside | |
| 2022-05-11 | Piper SandlerJessica Tassan | $21 | 1120.9% upside | |
| 2022-03-02 | Evercore ISIElizabeth Anderson CFA | $48 | 2690.7% upside | |
| 2022-03-02 | RBC CapitalSean Dodge | $35 | 1934.9% upside | |
| 2022-02-11 | Goldman SachsCindy Motz CFA | $48 | 2690.7% upside | |
| 2021-05-27 | GuggenheimSandy Draper | $60 | 3388.4% upside | |
| 2021-05-07 | Cantor FitzgeraldSteven Halper | $60 | 3388.4% upside | |